Clinical Trial Update: Testosterone TRANSdermal Gel for Poor Ovarian Responders Trial [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating testosterone transdermal gel for poor ovarian responders has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility
• Poor Ovarian Response

Drugs mentioned

• Testosterone transdermal gel (testosterone)

Snippet

Sponsor: Fundacion Dexeus | Conditions: Infertility, Poor Ovarian Response | Phase 3 | Status: TERMINATED